fda bpc-157 compounding restrictions Approval Status: Is It Approved for Human Use? Regulatory Alert: The Legal Status
Description
A unique characteristic of this orally administered peptide is its restriction to the gut, resulting in a localized effect
301 , G919G928 (2011)
BMJ Open
BPC-157 is often used alongside other peptides like TB-500
Light Sensitivity: Keep vials away from direct UV light exposure
